Varicella, Rubella and Rubeola
Publisher
Springer Singapore
Reference51 articles.
1. Saadatian-Elahi M, Mekki Y, Del Signore C, Lina B, Derrough T, Caulin E, et al. Seroprevalence of varicella antibodies among pregnant women in Lyon-France. Eur J Epidemiol. 2007;22(6):405–9.
2. Cohen A, Moschopoulos P, Stiehm RE, Koren G. Congenital varicella syndrome: the evidence for secondary prevention with varicella-zoster immune globulin. CMAJ. 2011;183(2):204–8.
3. Watson B, Civen R, Reynolds M, et al. Validity of self-reported varicella disease history in pregnant women attending prenatal clinics. Public Health Rep. 2007;122(4):499–506.
4. Plans P, Costa J, Espuñes J, et al. Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age. BJOG. 2007;114(9):1122–7.
5. Zhang HJ, Patenaude V, Abenhaim HA. Maternal outcomes in pregnancies affected by varicella zoster virus infections: population-based study on 7.7 million pregnancy admissions. J Obstet Gynaecol Res. 2015;41(1):62–8.